REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
36 hedge funds and large institutions have $27.1M invested in REVIVA PHARMA HLDGS INC in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 3 closing their positions.
467% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 3
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
109% more capital invested
Capital invested by funds: $13M → $27.1M (+$14.1M)
57% more funds holding
Funds holding: 23 → 36 (+13)
0.36% more ownership
Funds ownership: 0.59% → 0.94% (+0.36%)
0% more call options, than puts
Call options by funds: $3.48M | Put options by funds: $3.48M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$5.22M |
| 2 |
Millennium Management
New York
|
+$1.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.61M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$923K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$695K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$580K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$342K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$218K |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$207K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$42K |
RVPH Hedge Fund Activity: Q4 2023 in Review
36 of the 6,864 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2023, worth a combined $27.1M — up 109% from $13M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new RVPH positions and 3 closed out — a net gain of 14 holders — while 13 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, adding an estimated $5.22M. The largest seller was Group One Trading, exiting entirely with an estimated $580K sold.
- 36 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2023, up from 23 in Q3 2023.
- Funds reported $27.1M of REVIVA PHARMA HLDGS INC stock for Q4 2023, up 109% quarter-over-quarter.
- 17 funds opened new REVIVA PHARMA HLDGS INC positions in Q4 2023 and 3 closed out, a net change of +14 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q4 2023 was Armistice Capital, an estimated $5.22M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q4 2023 was Group One Trading, an estimated $580K sold.
Based on aggregated 13F filings for Q4 2023.